Trastuzumab News and Research

RSS
Researchers identify a potential target for small cell lung cancer

Researchers identify a potential target for small cell lung cancer

Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy

Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy

New material identifies cancer cells and mounts a surprising attack

New material identifies cancer cells and mounts a surprising attack

Sub-Saharan Africa needs greater access to live-saving antibodies

Sub-Saharan Africa needs greater access to live-saving antibodies

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Reducing the incidence of drug-induced interstitial lung disease in breast cancer patients

Combination therapy improves survival rates for women with aggressive endometrial cancer

Combination therapy improves survival rates for women with aggressive endometrial cancer

Rice lab's fluorescent tag project reveals new method to kill tumors

Rice lab's fluorescent tag project reveals new method to kill tumors

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Trastuzumab emtansine as a preferred second-line choice after horizontal dual blockade

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Statins may protect against heart damage caused by breast cancer therapies

Statins may protect against heart damage caused by breast cancer therapies

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

Targeting PI3Kβ alone and with combination therapy in PTEN-deficient tumors

NCCN publishes recommendations for assessing quality improvements in cancer care

NCCN publishes recommendations for assessing quality improvements in cancer care

New antibody-drug conjugate shows promising activity in salivary gland tumors

New antibody-drug conjugate shows promising activity in salivary gland tumors

Obesity linked to increased risk of cardiotoxicity in chemotherapy-treated patients with breast cancer

Obesity linked to increased risk of cardiotoxicity in chemotherapy-treated patients with breast cancer

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Cancer patients receiving common heart drugs have less heart damage from cancer therapy

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Biosimilar for HER2+ breast cancer achieves similar overall response rate to reference drug

Promising method to identify aggressive breast cancers that will respond to immunotherapy

Promising method to identify aggressive breast cancers that will respond to immunotherapy

Key metabolic changes found in patients with chemotherapy-related heart toxicity

Key metabolic changes found in patients with chemotherapy-related heart toxicity